Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen (Q34642136)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q37068027)
(Q37387600)
(P304) 3499-3506
(P407) (Q1860)
(P433) 28
(P478) 30
(P577) Tuesday, September 4, 2012
(P921) (Q42824827)
(Q181600)
(Q188874)
(Q422327)
(Q108566365)
(Q25493920)
(Q4689286)
(Q412197)
(Q238512)
(P1433) (Q400292)
(P1476) "Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen" (language: en)
(P2093) Radek Lakomy
Hans Prenen
Jana Prausová
Teresa Macarulla
Paul Ruff
Guy A van Hazel
Vladimir Moiseyenko
David Ferry
Joe McKendrick
Jonathan Polikoff
Alexia Tellier
Rémi Castan
Carmen Allegra
other details
description scientific article

External Links